SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-071944
Filing Date
2022-06-16
Accepted
2022-06-16 16:39:04
Documents
2
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm221864d-7_3.html 3  
1 FORM 3 tm221864d-7_3.xml 3 1625
2 EXHIBIT 24 tm2218645d7_ex24.htm EX-24 6579
  Complete submission text file 0001104659-22-071944.txt   9676
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2125 1ST AVENUE #2902 SEATTLE WA 98121-2121
Business Address
Ferguson Kenneth M. (Reporting) CIK: 0001934344 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 221021114